← Leaderboards
Anthony J Berdis
Case Western Reserve University
$1,355,792
Attributed
$1,546,142
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $241.7K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,546,142 · 2
By mechanism
R01$1,165,441 · 1
R21$380,701 · 1
Top collaborators
- Derek James Taylor2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Baowei Fei$6,556,619
- Daniel Eidelberg Spratt$5,099,108
- Mahmoud A Ghannoum$11,503,516
- Vikas Gulani$3,445,099
- Lee Evan Ponsky$1,082,740
Others in their field
Top investigators on “Cancer Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$181,009,042
- Larry Arthur$41,510,805
- Steven A Belinsky · Lovelace Biomedical &Environmental Res$26,419,484
- David H Haussler · University Of California Santa Cruz$25,140,916
- William C Hahn · Dana-Farber Cancer Institute$24,401,088
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$24,172,074
Research focus
Cancer Cell LineBinding (Molecular Function)PlayCellsEnzymesDesignNucleosidesNucleotidesBaseDna DamageMalignant NeoplasmsAnalogDna BiosynthesisCell Cycle ProgressionBehaviorDependency (Psychology)Cell CycleCyclinsCyclin-Dependent KinasesCytotoxicCytotoxicityCell Cycle DeregulationChemopreventive AgentCell Death Induction
Grant awards (7)
Targeting Telomerase in Pancreateic Cancer$163,276
R21 · FY2014 · CA
Targeting Telomerase in Pancreateic Cancer$217,425
R21 · FY2013 · CA
Non-natural Nucleoside Inhibitors of DNA Polymerases$229,214
R01 · FY2009 · CA · contact PI
Non-natural Nucleoside Inhibitors of DNA Polymerases$229,214
R01 · FY2008 · CA · contact PI
Non-natural Nucleoside Inhibitors of DNA Polymerases$229,214
R01 · FY2007 · CA · contact PI
Non-natural Nucleoside Inhibitors of DNA Polymerases$236,059
R01 · FY2006 · CA · contact PI
Non-natural Nucleoside Inhibitors of DNA Polymerases$241,740
R01 · FY2005 · CA